Michael Thomas

Real‐World Experience With Multimodal Treatment of Resectable Stage II – III Non‐Small Cell Lung Cancer: A Single Institutional Analysis

ABSTRACT Neoadjuvant therapy has recently become an integral component of multimodal treatment for resectable lung cancer. However, real‐world data on perioperative morbidity and treatment adherence remain limited. This study aimed to assess the feasibility and safety of differen...